Vol.57 No.1 January 2009
Evaluation of levofloxacin dosage regimens to prevent the appearance of resistant mutants in Streptococcus pneumoniae and Escherichia coli using an in vitro simulation model
Jpn. J. Chemother. 57 (1): 1-14, 2009
Multicenter, open-label study of the sustained-release formulation of azithromycin (azithromycin SR) for treatment of acute bronchitis and secondary infection of chronic respiratory disease
Jpn. J. Chemother. 57 (1): 15-25, 2009
Susceptibility of Pseudomonas aeruginosa isolates from blood and other clinical specimens of same patients to antibacterial agents
Jpn. J. Chemother. 57 (1): 26-31, 2009
The prevalence of β-lactamase non-producing ampicillin-resistant Haemophilus influenzae(BLNAR) isolated from respiratory samples and investigation of the susceptibility trends in Nagasaki University Hospital from 2000 to 2006
Jpn. J. Chemother. 57 (1): 32-36, 2009
Prevalence of drug resistant gene and changes in susceptibility of methicillin-resistant Staphylococcus aureus strains isolated from 1990 to 2006 in Japan to antimicrobial agents
Jpn. J. Chemother. 57 (1): 37-40, 2009